DOJ Charges Glenmark With Generic Drug Price-Fixing
The U.S. Department of Justice announced new criminal charges late Tuesday in its investigation of price-fixing in the generic-drug industry, this time accusing Glenmark Pharmaceuticals Inc. USA in Pennsylvania federal court...To view the full article, register now.
Already a subscriber? Click here to view full article